New to Meducation?
Sign up
Already signed up? Log In

Category

0
1
17

The Emerging Role of Molecular Markers in Non-Small Cell Lung Cancer: a Webinar by Dr. Nathan Pennell (video)

<p><span style="font-family: arial, sans, sans-serif; font-size: 13px; white-space: pre-wrap;">Dr. Nathan Pennell, medical oncologist and lung cancer expert at the Cleveland Clinic Foundation, reviews the current evidence and future directions for use of molecular markers such as EGFR, KRAS, ERCC-1, EML4-ALK, and others in NSCLC.</span></p>  
Howard (Jack) West, MD
about 8 years ago
1
1
28

Interview with Dr. Matthew Horton, Pathologist Part 2: Neuroendocrine Lung Tumors and Bronchioloalveolar Carcinoma (audio)

<p><font face="'Lucida Grande', Arial, Helvetica, sans-serif" size="3"><span style="font-size: 11px; white-space: pre-wrap;"><span style="font-family: Times; font-size: medium; white-space: normal;" <div style="color: #000000; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 10px; background-image: initial; background-repeat: initial; background-attachment: initial; background-color: #ffffff; background-position: initial initial; margin: 8px;" <p><font face="'Lucida Grande', Arial, Helvetica, sans-serif" size="3"><span style="font-size: 11px; white-space: pre-wrap;"><span style="font-family: arial, sans, sans-serif; font-size: 13px;">Dr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses the neuroendocrine spectrum of lung tumors and the evolving views on bronchioloalveolar carcinoma (BAC).</span></span></font></p </div </span></span></font></p>  
Howard (Jack) West, MD
about 8 years ago
2
1
30

Interview with Dr. Matthew Horton, Pathologist Part 2: Neuroendocrine Lung Tumors and Bronchioloalveolar Carcinoma (video)

<p><font face="'Lucida Grande', Arial, Helvetica, sans-serif" size="3"><span style="font-size: 11px; white-space: pre-wrap;"><span style="font-family: arial, sans, sans-serif; font-size: 13px;">Dr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses the neuroendocrine spectrum of lung tumors and the evolving views on bronchioloalveolar carcinoma (BAC).</span></span></font></p>  
Howard (Jack) West, MD
about 8 years ago
3
0
54

Interview with Dr. Matthew Horton, Pathologist Part 1: Basics of Non-Small Cell Lung Cancer Subtypes (audio)

Dr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses the basic subtypes of non-small cell lung cancer (NSCLC), methods of interpreting NSCLC histology, and the changing importance of pathology in NSCLC management.  
Howard (Jack) West, MD
about 8 years ago
4
1
46

Interview with Dr. Matthew Horton, Pathologist Part 1: Basics of Non-Small Cell Lung Cancer Subtypes (video)

Dr. Matthew Horton, specialist in lung pathology at CellNetix in Seattle, WA, discusses the basic subtypes of non-small cell lung cancer (NSCLC), methods of interpreting NSCLC histology, and the changing importance of pathology in NSCLC management.  
Howard (Jack) West, MD
about 8 years ago
5
1
9

Thought Leader Round Table: Drs Laskin and Sandler, Part 2 (audio)

Lung cancer experts Janessa Laskin and Alan Sandler sit down with medical oncologist Jack West to discuss complex cases. Focus on first line chemo standards and the transition to maintenance therapy.  
Howard (Jack) West, MD
about 8 years ago
6
1
2

Thought Leader Round Table: Drs Laskin and Sandler, Part 2 (video)

Lung cancer experts Janessa Laskin and Alan Sandler sit down with medical oncologist Jack West to discuss complex cases. Focus on first line chemo standards and the transition to maintenance therapy.  
Howard (Jack) West, MD
about 8 years ago
7
1
9

Thought Leader Round Table: Drs Laskin and Sandler, Part 1 (audio)

Lung cancer experts Janessa Laskin and Alan Sandler sit down with medical oncologist Jack West to discuss complex cases. Focus on never-smokers and EGFR mutation testing.  
Howard (Jack) West, MD
about 8 years ago
8
1
6

Thought Leader Round Table: Drs Laskin and Sandler, Part 1 (video)

Lung cancer experts Janessa Laskin and Alan Sandler sit down with medical oncologist Jack West to discuss complex cases. Focus on never-smokers and EGFR mutation testing.  
Howard (Jack) West, MD
about 8 years ago
13
1
8

Introduction to First Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (audio)

This slide presentation by Dr. Alan Sandler, medical oncologist and Division Chief of Hematology/Oncology at Oregon Health & Science University, provides an introduction to our current first line treatment options for metastatic NSCLC.  
Howard (Jack) West, MD
about 8 years ago
0
1
5

Introduction to First Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (video)

This slide presentation by Dr. Alan Sandler, medical oncologist and Division Chief of Hematology/Oncology at Oregon Health & Science University, provides an introduction to our current first line treatment options for metastatic NSCLC.  
Howard (Jack) West, MD
about 8 years ago
1
1
12

Treating Lung Cancer: Past, Present, and Future (Audio)

This slide presentation by Dr. Ramiswamy Govindan, medical oncologist at Washington University in St. Louis, offers a broad perspective on the history of treating cancer with chemotherapy, our current treatment approaches, and a preview of emerging technologies that are poised to become a more individualized way of treating cancer.  
Howard (Jack) West, MD
about 8 years ago
2
2
13

Treating Lung Cancer: Past, Present, and Future (Video)

This slide presentation by Dr. Ramiswamy Govindan, medical oncologist at Washington University in St. Louis, offers a broad perspective on the history of treating cancer with chemotherapy, our current treatment approaches, and a preview of emerging technologies that are poised to become a more individualized way of treating cancer.  
Howard (Jack) West, MD
about 8 years ago
3
1
9

Surgical vs. Non-Surgical Management of Locally Advanced NSCLC (Audio)

This slide presentation by Dr. Shirish Gadgeel, medical oncologist at Wayne State University, discusses the considerations and evidence about whether locally advanced (Stage III) NSCLC should be managed surgically or with chemo/radiation alone.  
Howard (Jack) West, MD
about 8 years ago
4
1
5

Surgical vs. Non-Surgical Management of Locally Advanced NSCLC (Video)

This slide presentation by Dr. Shirish Gadgeel, medical oncologist at Wayne State University, discusses the considerations and evidence about whether locally advanced (Stage III) NSCLC should be managed surgically or with chemo/radiation alone.  
Howard (Jack) West, MD
about 8 years ago
7
1
3

Adjuvant (Post-Operative) Therapy for Resected Early Stage NSCLC (Video)

This slide presentation by Dr. Heather Wakelee, medical oncologist at Stanford University, describes the current evidence supporting post-operative treatment of resected non-small cell lung cancer (NSCLC) and leading trials in the field.  
Howard (Jack) West, MD
about 8 years ago
8
1
7

Adjuvant (Post-Operative) Therapy for Resected Early Stage NSCLC (Audio)

This slide presentation by Dr. Heather Wakelee, medical oncologist at Stanford University, describes the current evidence supporting post-operative treatment of resected non-small cell lung cancer (NSCLC) and leading trials in the field.  
Howard (Jack) West, MD
about 8 years ago
11
1
5

Diagnosis and Staging of Lung Cancer: A Pulmonologist's Perspective (Audio)

This slide presentation by Dr. Gerard Silvestri, pulmonologist at Medical Univ. of South Carolina, covers the key methods of evaluating a new lung cancer, including initial diagnosis and staging studies.  
Howard (Jack) West, MD
about 8 years ago
12
2
16

Diagnosis and Staging of Lung Cancer: A Pulmonologist's Perspective (Video)

This slide presentation by Dr. Gerard Silvestri, pulmonologist at Medical Univ. of South Carolina, covers the key methods of evaluating a new lung cancer, including initial diagnosis and staging studies.  
Howard (Jack) West, MD
about 8 years ago
13
2
8

Current Questions and Clinical Trials in Post-Operative/Adjuvant Therapy for Early Stage NSCLC (Audio)

This slide presentation by Dr. Heather Wakelee, medical oncologist at Stanford University, describes the key clinical research issues being addressed in post-operative treatment of resected non-small cell lung cancer (NSCLC).  
Howard (Jack) West, MD
about 8 years ago